Page 26 - Read Online

Tulotta et al. J Cancer Metastasis Treat 2019;5:74 I http://dx.doi.org/10.20517/2394-4722.2019.022 Page 11 of 11

heterogeneous for CXCR4 expression. Proc Natl Acad Sci U S A 2000;97:14626-31.
75. Day RB, Link DC. Regulation of neutrophil trafficking from the bone marrow. Cell Mol Life Sci 2012;69:1415-23.
76. Sallusto F, Baggiolini M. Chemokines and leukocyte traffic. Nat Immunol 2008;9:949-52.
77. Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu
Rev Immunol 2000;18:593-620.
78. Bussmann J, Raz E. Chemokine-guided cell migration and motility in zebrafish development. EMBO J 2015;34:1309-18.
79. Vicenzi E, Lio P, Poli G. The puzzling role of CXCR4 in human immunodeficiency virus infection. Theranostics 2013;3:18-25.
80. Gulino AV. WHIM syndrome: a genetic disorder of leukocyte trafficking. Curr Opin Allergy Clin Immunol 2003;3:443-50.
81. Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 2004;14:171-9.
82. Chatterjee S, Behnam Azad B, Nimmagadda S. The intricate role of CXCR4 in cancer. Adv Cancer Res 2014;124:31-82.
83. Saini V, Marchese A, Majetschak M. CXC chemokine receptor 4 is a cell surface receptor for extracellular ubiquitin. J Biol Chem
2010;285:15566-76.
84. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, et al. MIF is a noncognate ligand of CXC chemokine receptors in
inflammatory and atherogenic cell recruitment. Nat Med 2007;13:587-96.
85. Lourenco S, Teixeira VH, Kalber T, Jose RJ, Floto RA, et al. Macrophage migration inhibitory factor-CXCR4 is the dominant
chemotactic axis in human mesenchymal stem cell recruitment to tumors. J Immunol 2015;194:3463-74.
86. Shin HN, Moon HH, Ku JL. Stromal cell-derived factor-1alpha and macrophage migration-inhibitory factor induce metastatic
behavior in CXCR4-expressing colon cancer cells. Int J Mol Med 2012;30:1537-43.
87. Lu J, Chatterjee M, Schmid H, Beck S, Gawaz M. CXCL14 as an emerging immune and inflammatory modulator. J Inflamm (Lond)
2016;13:1.
88. Muller A, Homey B, Soto H, Ge N, Catron D, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature
2001;410:50-6.
89. Weidle UH, Birzele F, Kollmorgen G, Ruger R. Molecular mechanisms of bone metastasis. Cancer Genomics Proteomics 2016;13:1-12.
90. Ottewell PD, O’Donnell L, Holen I. Molecular alterations that drive breast cancer metastasis to bone. Bonekey Rep 2015;4:643.
91. Martinez-Ordonez A, Seoane S, Cabezas P, Eiro N, Sendon-Lago J, et al. Breast cancer metastasis to liver and lung is facilitated by
Pit-1-CXCL12-CXCR4 axis. Oncogene 2018;37:1430-44.
92. Seoane S, Martinez-Ordonez A, Eiro N, Cabezas-Sainz P, Garcia-Caballero L, et al. POU1F1 transcription factor promotes breast
cancer metastasis via recruitment and polarization of macrophages. J Pathol 2019;249:381-94.
93. Tulotta C, Stefanescu C, Beletkaia E, Bussmann J, Tarbashevich K, et al. Inhibition of signaling between human CXCR4 and zebrafish
ligands by the small molecule IT1t impairs the formation of triple-negative breast cancer early metastases in a zebrafish xenograft
model. Dis Model Mech 2016;9:141-53.
94. Cook AM, Lesterhuis WJ, Nowak AK, Lake RA. Chemotherapy and immunotherapy: mapping the road ahead. Curr Opin Immunol
2016;39:23-9.
95. Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buque A, Senovilla L, et al. Classification of current anticancer immunotherapies.
Oncotarget 2014;5:12472-508.
96. Tchernychev B, Ren Y, Sachdev P, Janz JM, Haggis L, et al. Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow
hematopoietic cells. Proc Natl Acad Sci U S A 2010;107:22255-9.
97. Walters KB, Green JM, Surfus JC, Yoo SK, Huttenlocher A. Live imaging of neutrophil motility in a zebrafish model of WHIM
syndrome. Blood 2010;116:2803-11.
98. Isles HM, Herman KD, Robertson AL, Loynes CA, Prince LR, et al. The CXCL12/CXCR4 signaling axis retains neutrophils at
inflammatory sites in Zebrafish. Front Immunol 2019;10:1784.
99. Tulotta C, Stefanescu C, Chen Q, Torraca V, Meijer AH, et al. CXCR4 signaling regulates metastatic onset by controlling neutrophil
motility and response to malignant cells. Sci Rep 2019;9:2399.
100. Demicheli R, Retsky MW, Hrushesky WJ, Baum M, Gukas ID. The effects of surgery on tumor growth: a century of investigations.
Ann Oncol 2008;19:1821-8.
101. Sounni NE, Noel A. Targeting the tumor microenvironment for cancer therapy. Clin Chem 2013;59:85-93.